Kantarjian, H.M.; Zugmaier, G.; Brüggemann, M.; Wood, B.L.; Horst, H.A.; Zeng, Y.; Martinelli, G.
Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Cancers 2021, 13, 5607.
https://doi.org/10.3390/cancers13225607
AMA Style
Kantarjian HM, Zugmaier G, Brüggemann M, Wood BL, Horst HA, Zeng Y, Martinelli G.
Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Cancers. 2021; 13(22):5607.
https://doi.org/10.3390/cancers13225607
Chicago/Turabian Style
Kantarjian, Hagop M., Gerhard Zugmaier, Monika Brüggemann, Brent L. Wood, Heinz A. Horst, Yi Zeng, and Giovanni Martinelli.
2021. "Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia" Cancers 13, no. 22: 5607.
https://doi.org/10.3390/cancers13225607
APA Style
Kantarjian, H. M., Zugmaier, G., Brüggemann, M., Wood, B. L., Horst, H. A., Zeng, Y., & Martinelli, G.
(2021). Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Cancers, 13(22), 5607.
https://doi.org/10.3390/cancers13225607